Stockscreener 앱 받기
41.48
0.53%
-0.18
전일 마감가:
$41.66
열려 있는:
$41.75
하루 거래량:
40,869
Relative Volume:
0.17
시가총액:
$502.64M
수익:
$52.15M
순이익/손실:
$24.35M
주가수익비율:
28.52
EPS:
1.4544
순현금흐름:
$-17.93M
1주 성능:
+1.10%
1개월 성능:
+22.79%
6개월 성능:
+21.63%
1년 성능:
+79.86%
1일 변동 폭
$41.42
$41.75
1주일 범위
$40.61
$41.85
52주 변동 폭
$22.29
$42.81
Xoma Royalty Corp Stock (XOMA) Company Profile
명칭
Xoma Royalty Corp
전화
510-204-7239
주소
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
41.44 | 505.31M | 52.15M | 24.35M | -17.93M | 1.4544 |
VRTX
Vertex Pharmaceuticals Inc
|
427.90 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
719.10 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.30 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.71 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
314.06 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 개시 | The Benchmark Company | Buy |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2021-09-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-06-29 | 개시 | Aegis Capital | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-17 | 재개 | H.C. Wainwright | Buy |
| 2017-09-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2017-06-12 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-11 | 재확인 | Wedbush | Outperform |
| 2015-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-07-22 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 재개 | ROTH Capital | Buy |
| 2014-04-29 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-11 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2014-03-05 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-10-31 | 재확인 | MLV & Co | Buy |
| 2013-05-09 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-14 | 개시 | Cowen & Co | Outperform |
| 2011-03-31 | 재확인 | MLV Capital | Buy |
| 2011-03-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2011-01-06 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-01-04 | 재확인 | Wedbush | Outperform |
모두보기
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
XOMA (XOMA) holders offered $39 cash plus CVRs in Ligand buyout - Stock Titan
Ligand Pharmaceuticals Launches Takeover Plan at XOMA Royalty Corporation with 47.0% Stake - TradingView
This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Sahm
[SCHEDULE 13G] XOMA Royalty Corp Passive Investment Disclosure (>5%) - Stock Titan
H.C. Wainwright cuts XOMA stock rating on Ligand acquisition - Investing.com
HC Wainwright & Co. downgrades XOMA Royalty (XOMA) - MSN
BVF group backs XOMA Royalty Corp (XOMA) merger with 21.4% locked-up stake - Stock Titan
LGND: XOMA Buy Adds 100+ Assets - Yahoo Finance
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire Inc.
Ligand to acquire XOMA Royalty - The Pharma Letter
XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last? - Yahoo Finance
Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook - MarketBeat
BlackRock (NASDAQ: XOMA) reports 5.4% stake in XOMA Royalty Corp - Stock Titan
XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve
HC Wainwright & Co. maintains XOMA Royalty (XOMA) buy recommendation - MSN
Promising Biotech Stocks To Watch TodayApril 27th - MarketBeat
Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga
Ligand Is Buying Xoma Royalty For $739 Million In Cash - Finimize
Ligand Pharmaceuticals Incorporated entered into a definitive agreement to acquire XOMA Royalty Corporation for approximately $470 million from BVF Partners L.P. and others. - marketscreener.com
Ademi LLP Investigates XOMA for Possible Violations - Intellectia AI
Xoma Royalty Corp - Reuters
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Benzinga
Ademi LLP Investigates Whether XOMA Royalty Corporation Is Obtaining a Fair Price for Public Shareholders - Moomoo
Ligand (Nasdaq: LGND) to acquire XOMA Royalty in $739M, EPS‑accretive deal - Stock Titan
Ligand Pharmaceuticals buying Xoma Royalty for $739 million - Yahoo Finance
Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million, Expanding Biopharma Royalty Portfolio and Boosting 2026 EPS Guidance - Minichart
XOMA Royalty to Be Acquired by Ligand in $39-Per-Share Cash Deal Plus CVRs - TradingView
XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders - Business Wire
Ligand to buy XOMA Royalty (Nasdaq: XOMA) in $739M cash and CVR deal - Stock Titan
XOMA Royalty: Transaction Is Expected to Close in the 3Q of 2026 >XOMA - Moomoo
Ligand to acquire XOMA Royalty for $739 million in cash - Investing.com
Ligand to acquire XOMA Royalty for $739 million in cash By Investing.com - Investing.com Australia
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator - The Manila Times
XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill
XOMA Royalty (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
XOMA (XOMA) CFO converts 11,538 Performance Stock Units into common shares - Stock Titan
XOMA (XOMA) legal chief converts 3,370 PSUs into common shares - Stock Titan
XOMA (XOMA) CEO Owen Hughes exercises 10,568 PSUs and updates holdings - Stock Titan
XOMA (XOMA) CIO boosts direct common holdings via 3,737 PSU conversion - Stock Titan
XOMA Technical Analysis & Stock Price Forecast - Intellectia AI
XOMA ROYALTY CORPXOMA 8 3/8 PERP (NASDAQ:XOMAO) Checks All Eight Boxes in Navellier’s Little Book Growth Screen - ChartMill
XOMA (XOMA) CFO exercises 4,000 PSUs, 1,632 shares withheld for taxes - Stock Titan
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
Published on: 2026-04-13 23:42:40 - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan
Retail Surge: Is now the right time to enter XOMA Royalty Corporation2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn
Xoma Royalty Corp (XOMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
3.01%
자본화:
|
볼륨(24시간):